BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Delalio LJ, Best AK, Macal E, Milstein J, Donnelly I, Miller AM, McBride M, Shu X, Koval M, Isakson BE, Johnstone SR. Endothelial Pannexin 1 Channels Control Inflammation by Regulating Intracellular Calcium. J Immunol 2020;204:2995-3007. [PMID: 32312847 DOI: 10.4049/jimmunol.1901089] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Lee MD, Buckley C, Wilson C, McCarron JG. Mitochondria regulate TRPV4-mediated release of ATP. Br J Pharmacol 2021. [PMID: 34605007 DOI: 10.1111/bph.15687] [Reference Citation Analysis]
2 Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, Galluzzi L. ATP and cancer immunosurveillance. EMBO J 2021;40:e108130. [PMID: 34121201 DOI: 10.15252/embj.2021108130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wu B, Gao F, Lin J, Lu L, Xu H, Xu GT. Conditioned Medium of Human Amniotic Epithelial Cells Alleviates Experimental Allergic Conjunctivitis Mainly by IL-1ra and IL-10. Front Immunol 2021;12:774601. [PMID: 34880869 DOI: 10.3389/fimmu.2021.774601] [Reference Citation Analysis]
4 Strassheim D, Verin A, Batori R, Nijmeh H, Burns N, Kovacs-Kasa A, Umapathy NS, Kotamarthi J, Gokhale YS, Karoor V, Stenmark KR, Gerasimovskaya E. P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases. Int J Mol Sci 2020;21:E6855. [PMID: 32962005 DOI: 10.3390/ijms21186855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Huang Y, Lin J, Chen X, Lin J. Pannexin-1 Contributes to the Apoptosis of Spinal Neurocytes in Spinal Cord Injury. Front Physiol 2021;12:656647. [PMID: 33986693 DOI: 10.3389/fphys.2021.656647] [Reference Citation Analysis]
6 Haywood N, Ta HQ, Rotar E, Daneva Z, Sonkusare SK, Laubach VE. Role of the purinergic signaling network in lung ischemia-reperfusion injury. Curr Opin Organ Transplant 2021;26:250-7. [PMID: 33651003 DOI: 10.1097/MOT.0000000000000854] [Reference Citation Analysis]
7 Maldifassi MC, Momboisse F, Guerra MJ, Vielma AH, Maripillán J, Báez-Matus X, Flores-Muñoz C, Cádiz B, Schmachtenberg O, Martínez AD, Cárdenas AM. The interplay between α7 nicotinic acetylcholine receptors, pannexin-1 channels and P2X7 receptors elicit exocytosis in chromaffin cells. J Neurochem 2021;157:1789-808. [PMID: 32931038 DOI: 10.1111/jnc.15186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Daneva Z, Ottolini M, Chen YL, Klimentova E, Kuppusamy M, Shah SA, Minshall RD, Seye CI, Laubach VE, Isakson BE, Sonkusare SK. Endothelial pannexin 1-TRPV4 channel signaling lowers pulmonary arterial pressure in mice. Elife 2021;10:e67777. [PMID: 34490843 DOI: 10.7554/eLife.67777] [Reference Citation Analysis]
9 Nadeali Z, Rezaei FM, Aria H, Nikpour P. Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120482] [Reference Citation Analysis]
10 Andelova K, Egan Benova T, Szeiffova Bacova B, Sykora M, Prado NJ, Diez ER, Hlivak P, Tribulova N. Cardiac Connexin-43 Hemichannels and Pannexin1 Channels: Provocative Antiarrhythmic Targets. Int J Mol Sci 2020;22:E260. [PMID: 33383853 DOI: 10.3390/ijms22010260] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ling ZM, Wang Q, Ma Y, Xue P, Gu Y, Cao MH, Wei ZY. Astrocyte Pannexin 1 Suppresses LPS-Induced Inflammatory Responses to Protect Neuronal SH-SY5Y Cells. Front Cell Neurosci 2021;15:710820. [PMID: 34475813 DOI: 10.3389/fncel.2021.710820] [Reference Citation Analysis]
12 Sanchez-Arias JC, van der Slagt E, Vecchiarelli HA, Candlish RC, York N, Young PA, Shevtsova O, Juma A, Tremblay MÈ, Swayne LA. Purinergic signaling in nervous system health and disease: Focus on pannexin 1. Pharmacol Ther 2021;225:107840. [PMID: 33753132 DOI: 10.1016/j.pharmthera.2021.107840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Prieto-Villalobos J, Alvear TF, Liberona A, Lucero CM, Martínez-Araya CJ, Balmazabal J, Inostroza CA, Ramírez G, Gómez GI, Orellana JA. Astroglial Hemichannels and Pannexons: The Hidden Link between Maternal Inflammation and Neurological Disorders. Int J Mol Sci 2021;22:9503. [PMID: 34502412 DOI: 10.3390/ijms22179503] [Reference Citation Analysis]
14 Sanchez Arias JC, Wicki-Stordeur LE, Candlish RC, van der Slagt E, Paci I, Rao PPN, MacVicar BA, Swayne LA. PANX1 in inflammation heats up: New mechanistic insights with implications for injury and infection. Cell Calcium 2020;90:102253. [PMID: 32688074 DOI: 10.1016/j.ceca.2020.102253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Kameritsch P, Pogoda K. The Role of Connexin 43 and Pannexin 1 During Acute Inflammation. Front Physiol 2020;11:594097. [PMID: 33192611 DOI: 10.3389/fphys.2020.594097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
16 Laird DW, Penuela S. Pannexin biology and emerging linkages to cancer. Trends Cancer 2021:S2405-8033(21)00147-3. [PMID: 34389277 DOI: 10.1016/j.trecan.2021.07.002] [Reference Citation Analysis]
17 Koval M, Cwiek A, Carr T, Good ME, Lohman AW, Isakson BE. Pannexin 1 as a driver of inflammation and ischemia-reperfusion injury. Purinergic Signal 2021. [PMID: 34251590 DOI: 10.1007/s11302-021-09804-8] [Reference Citation Analysis]
18 Varela-Vázquez A, Guitián-Caamaño A, Carpintero-Fernandez P, Fonseca E, Sayedyahossein S, Aasen T, Penuela S, Mayán MD. Emerging functions and clinical prospects of connexins and pannexins in melanoma. Biochim Biophys Acta Rev Cancer 2020;1874:188380. [PMID: 32461135 DOI: 10.1016/j.bbcan.2020.188380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Swayne LA, Johnstone SR, Ng CS, Sanchez-Arias JC, Good ME, Penuela S, Lohman AW, Wolpe AG, Laubach VE, Koval M, Isakson BE. Consideration of Pannexin 1 channels in COVID-19 pathology and treatment. Am J Physiol Lung Cell Mol Physiol 2020;319:L121-5. [PMID: 32519892 DOI: 10.1152/ajplung.00146.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]